Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

NCCN and Medlive Extend Collaboration to Improve Cancer Treatment in China

Wednesday, July 31, 2024

The National Comprehensive Cancer Network has extended its strategic partnership with Medlive continuing to make NCCN Clinical Practice Guidelines in Oncology available throughout China This ongoing collaboration will support the distribution of thes...

Akeso's sBLA for Ivonescimab in First-Line Therapy for PD-L1 Positive NSCLC Accepted by NMPA

Tuesday, July 30, 2024

Akeso is pleased to announce that the China National Medical Products Administration has accepted the supplemental biologics license application for ivonescimab injection the worlds first PDVEGF bispecific

Compugen Secures FDA Approval for IND Application of COM503 in Solid Tumor Treatment

Tuesday, July 30, 2024

Compugen Ltd a clinicalstage cancer immunotherapy company and a leader in computational target discovery has announced that the US Food and Drug Administration has approved their investigational

Astellas Receives Positive CHMP Recommendation for Zolbetuximab Combined with Chemotherapy in Treating Advanced Gastric and Gastroesophageal Junction Cancer

Monday, July 29, 2024

Astellas Pharma Incannounced on July that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval for zolbetuximab in the European Union

Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Achievements in Drug Innovation

Saturday, July 27, 2024

Eluminex Biosciences has revealed that their trispecific fusion antibody drug EB has been administered for the first time to a patient with diabetic macular edema in the United States

Ractigen Secures FDA Rare Pediatric Disease Designation for RAG-18 in Duchenne Muscular Dystrophy Treatment

Friday, July 26, 2024

Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG

IASO Bio Secures NMPA Approval to Begin Trials for IASO-782 in Systemic Lupus Erythematosus (SLE)

Friday, July 26, 2024

IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug

A.forall Secures FDA Approval for Fifth Generic Drug Application on First Submission Cycle

Friday, July 26, 2024

Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated

Eisai and EcoNaviSta Forge Business Partnership to Develop a Dementia Care Ecosystem and Initiate Collaboration

Thursday, July 25, 2024

Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta

Pfizer Reveals Successful Phase 3 Outcomes for Hemophilia A Gene Therapy Candidate

Thursday, July 25, 2024

Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A